Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1600 of 1631 entries
View as:

Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00310596 Org: User:
Start: 01/31/04 End: 03/31/04 Due: 03/31/05

Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban

Phase: N/A Priority: Normal
NCT ID: NCT01436526 Org: User:
Start: 08/31/09 End: 09/30/09 Due: 09/30/10

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients

Phase: N/A Priority: Normal
NCT ID: NCT04824729 Org: User:
Start: 03/24/21 End: 01/07/22 Due: 01/07/23

Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

Phase: N/A Priority: Normal
NCT ID: NCT03504982 Org: User:
Start: 05/17/18 End: 02/26/19 Due: 02/26/20

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02928029 Org: User:
Start: 02/10/17 End: 03/20/19 Due: 03/20/20

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

Phase: N/A Priority: Normal
NCT ID: NCT01067976 Org: User:
Start: 02/28/10 End: 01/31/12 Due: 01/31/13

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Phase: N/A Priority: Normal
NCT ID: NCT01690559 Org: User:
Start: 04/30/10 End: 01/31/12 Due: 01/31/13

Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)

Phase: N/A Priority: Normal
NCT ID: NCT00874640 Org: User:
Start: 03/31/09 End: 11/30/11 Due: 11/30/12

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00656188 Org: User:
Start: 10/31/02 End: 05/31/03 Due: 05/31/04

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01184833 Org: User:
Start: 09/30/08 End: 08/31/11 Due: 08/31/12

Treatment Satisfaction With Ra-223 in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03315260 Org: User:
Start: 04/11/19 End: 03/20/23 Due: 03/20/24

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02043678 Org: User:
Start: 03/30/14 End: 02/08/24 Due: 02/08/25

Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01853800 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00660998 Org: User:
Start: 02/28/03 End: 01/31/04 Due: 01/31/05

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Phase: N/A Priority: Normal
NCT ID: NCT02936492 Org: User:
Start: 10/24/16 End: 10/16/17 Due: 10/16/18

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

Phase: N/A Priority: Normal
NCT ID: NCT00393198 Org: User:
Start: 10/31/06 End: 10/31/12 Due: 10/31/13

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Phase: N/A Priority: Normal
NCT ID: NCT01968668 Org: User:
Start: 10/28/13 End: 11/07/14 Due: 11/07/15

Sun Protection Factor Assay (SPF Assay 207/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02936583 Org: User:
Start: 10/26/16 End: 11/01/16 Due: 11/01/17

Human Photoallergy Test

Phase: N/A Priority: Normal
NCT ID: NCT02751515 Org: User:
Start: 05/31/16 End: 07/31/16 Due: 07/31/17

A Drug Utilization Study of Radium-223 in Sweden

Phase: N/A Priority: Normal
NCT ID: NCT02331303 Org: User:
Start: 04/15/15 End: 12/19/17 Due: 12/19/18

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01331655 Org: User:
Start: 04/30/13 End: 11/30/14 Due: 11/30/15

A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04809805 Org: User:
Start: 04/15/21 End: 04/27/23 Due: 04/27/24

A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale

Phase: N/A Priority: Normal
NCT ID: NCT03570554 Org: User:
Start: 06/29/18 End: 06/14/19 Due: 06/14/20

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00300885 Org: User:
Start: 02/28/06 End: 02/28/09 Due: 02/28/10

Copanlisib Chinese PK Study

Phase: N/A Priority: Normal
NCT ID: NCT03498430 Org: User:
Start: 04/27/18 End: 06/02/20 Due: 06/02/21